Yacov must be completely out of cash to sell his shares for 6.6c!
Obviously nothing positive on the horizon to be dumping at those prices.
Hence the GEM facility to plug the Yacov funding hole.
For all the potential positives going for this company over the next 6 to 12 mths it certainly looks like the wheels have fallen off.
Obviously the announcement in regards to the US business was to pump up the share price for this sale. Problem was the announcement was full of shite. Those massive growth rates were all to do with the Telerymics acquisition in November last year. It would have been good to see the growth adjusted for this acquisition.
Let see if these new investors want more stock and support on market tomorrow.
Merry Christmas Yacov!
- Forums
- ASX - By Stock
- GMV
- Ann: Appendix 3Y - Change of Director's Interest Notice
Ann: Appendix 3Y - Change of Director's Interest Notice, page-4
-
- There are more pages in this discussion • 41 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add GMV (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online